Johnson & Johnson raised its full-year sales forecast on Wednesday after beating estimates for second-quarter profit on ...

Veranex, a global provider of product development and contract research services, today introduced the industry’s first ...

Stay updated on Johnson & Johnson's Q2 earnings as it faces tariff threats, MedTech challenges, and legal risks.

Johnson & Johnson (NYSE: JNJ) shares ticked up before hours today on second-quarter results that came in ahead of the ...

Johnson & Johnson beat Q2 estimates and raised its 2025 outlook, driven by strong cancer and MedTech sales despite Stelara ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

Medical technology has been on the up for many years, and professionals and experts in Australia have been making strides in innovation over the last decade.

Steris (STE) stock and Solventum (SOLV) stock is upgraded, while RxSight (RXST) stock is downgraded at Morgan Stanley on valuations. Read more here.

Wells Fargo is expanding its healthcare team within its commercial bank and aims to hire more people at a time when the $1.95 ...

J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018″ peripheral ...